siRNA Drugs: Here to Stay.
作者信息
Rossi John J, Rossi Daniel J
机构信息
Department Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Istat Therapeutics, Inc., Duarte, CA, USA.
出版信息
Mol Ther. 2021 Feb 3;29(2):431-432. doi: 10.1016/j.ymthe.2021.01.015. Epub 2021 Jan 14.
Abstract
摘要
相似文献
1
siRNA Drugs: Here to Stay.小干扰RNA药物：前景光明。
Mol Ther. 2021 Feb 3;29(2):431-432. doi: 10.1016/j.ymthe.2021.01.015. Epub 2021 Jan 14.
2
siRNA nanomedicine: the promise of bioreducible materials.小干扰RNA纳米药物：可生物还原材料的前景
Expert Rev Med Devices. 2013 Jan;10(1):7-10. doi: 10.1586/erd.12.73.
3
Interfering with disease: opportunities and roadblocks to harnessing RNA interference.干预疾病：利用RNA干扰的机遇与障碍
Trends Mol Med. 2003 Sep;9(9):397-403. doi: 10.1016/s1471-4914(03)00143-6.
4
Multifunctional nanosystems: growing sanguinity in siRNA therapy.多功能纳米系统：siRNA疗法中日益增长的信心。
Int J Nanomedicine. 2014 Apr 10;9:1771-3. doi: 10.2147/IJN.S57440. eCollection 2014.
5
Innovations in siRNA research: a technology comes of age.小干扰RNA研究的创新：一项技术走向成熟。
Recent Pat Antiinfect Drug Discov. 2010 Nov;5(3):226-39. doi: 10.2174/157489110793348794.
6
Polycation-based nanoparticle delivery for improved RNA interference therapeutics.基于聚阳离子的纳米颗粒递送用于改善RNA干扰疗法。
Expert Opin Biol Ther. 2007 Dec;7(12):1811-22. doi: 10.1517/14712598.7.12.1811.
7
RNA interference in three humans.对三名人类进行RNA干扰。
Nat Biotechnol. 2010 Apr;28(4):335. doi: 10.1038/nbt0410-335.
8
Journey of siRNA: Clinical Developments and Targeted Delivery.siRNA 之旅：临床进展与靶向递送。
Nucleic Acid Ther. 2018 Aug;28(4):209-224. doi: 10.1089/nat.2017.0715. Epub 2018 Mar 27.
9
siRNA: novel therapeutics from functional genomics.小干扰RNA：功能基因组学的新型疗法。
Biotechnol Genet Eng Rev. 2014 Oct;30(1-2):1-30. doi: 10.1080/02648725.2014.921495.
10
Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery.用于siRNA递送的单克隆抗体偶联树突状纳米结构
Methods Mol Biol. 2019;1974:195-201. doi: 10.1007/978-1-4939-9220-1_14.
引用本文的文献
1
Full sequencing of 100mer sgRNA via tandem mass spectrometry by targeted RNase H digestion with customized probes.通过使用定制探针进行靶向核糖核酸酶H消化，利用串联质谱对100聚体单导向RNA进行全长测序。
Anal Bioanal Chem. 2025 Mar;417(8):1497-1506. doi: 10.1007/s00216-025-05737-y. Epub 2025 Jan 20.
2
Advancements in gene therapies targeting mutant KRAS in cancers.针对癌症中突变型KRAS的基因疗法进展。
Cancer Metastasis Rev. 2025 Jan 17;44(1):24. doi: 10.1007/s10555-025-10243-9.
3
Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy.利用植物源纳米囊泡进行先进的基于核酸的基因治疗。
Theranostics. 2025 Jan 1;15(1):324-339. doi: 10.7150/thno.104507. eCollection 2025.
4
Nucleic acid drugs: recent progress and future perspectives.核酸药物：最新进展与未来展望。
Signal Transduct Target Ther. 2024 Nov 29;9(1):316. doi: 10.1038/s41392-024-02035-4.
5
Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.长链非编码 RNA 在神经母细胞瘤中的作用：发病机制、生物标志物和治疗靶点。
Int J Mol Sci. 2024 May 23;25(11):5690. doi: 10.3390/ijms25115690.
6
dCas13-mediated translational repression for accurate gene silencing in mammalian cells.dCas13介导的翻译抑制用于在哺乳动物细胞中实现精确的基因沉默。
Nat Commun. 2024 Mar 11;15(1):2205. doi: 10.1038/s41467-024-46412-7.
7
Therapeutic synthetic and natural materials for immunoengineering.免疫工程用治疗性合成和天然材料
Chem Soc Rev. 2024 Feb 19;53(4):1789-1822. doi: 10.1039/d3cs00805c.
8
The emerging potential of siRNA nanotherapeutics in treatment of arthritis.小干扰RNA纳米疗法在关节炎治疗中的新兴潜力。
Asian J Pharm Sci. 2023 Sep;18(5):100845. doi: 10.1016/j.ajps.2023.100845. Epub 2023 Sep 16.
9
Quantification of Oligonucleotides Using Tandem Mass Spectrometry with Isobaric Internal Standards.采用等重内标物的串联质谱法对寡核苷酸进行定量分析。
Int J Mol Sci. 2023 Sep 28;24(19):14691. doi: 10.3390/ijms241914691.
10
Emerging roles of RNA binding proteins in intervertebral disc degeneration and osteoarthritis.RNA 结合蛋白在椎间盘退变和骨关节炎中的新兴作用。
Orthop Surg. 2023 Dec;15(12):3015-3025. doi: 10.1111/os.13851. Epub 2023 Oct 6.
本文引用的文献
1
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.GalNAc 介导的寡核苷酸递送至肝脏：从研究到注册治疗药物。
Mol Ther. 2020 Aug 5;28(8):1759-1771. doi: 10.1016/j.ymthe.2020.06.015. Epub 2020 Jun 17.
2
Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.超越肝脏：siRNA 治疗药物靶向递呈的进展与挑战。
J Control Release. 2015 Apr 10;203:1-15. doi: 10.1016/j.jconrel.2015.02.003. Epub 2015 Feb 4.
3
Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.经涂覆钢微针递送至皮肤的 siRNA 后的基因沉默：体内和体外概念验证。
J Control Release. 2013 Mar 28;166(3):211-9. doi: 10.1016/j.jconrel.2012.12.030. Epub 2013 Jan 8.
4
Unlocking the potential of the human genome with RNA interference.利用RNA干扰释放人类基因组的潜能。
Nature. 2004 Sep 16;431(7006):371-8. doi: 10.1038/nature02870.
5
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.小双链RNA在无脊椎动物和脊椎动物系统中对基因表达的特异性抑制
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9742-7. doi: 10.1073/pnas.171251798. Epub 2001 Jul 31.
6
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.21个核苷酸的RNA双链体在培养的哺乳动物细胞中介导RNA干扰。
Nature. 2001 May 24;411(6836):494-8. doi: 10.1038/35078107.
7
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.双链RNA在秀丽隐杆线虫中产生强大而特异的基因干扰作用。
Nature. 1998 Feb 19;391(6669):806-11. doi: 10.1038/35888.
Zotero 插件